Back to Search
Start Over
Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells).
- Source :
-
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2002 Mar; Vol. 300 (3), pp. 939-45. - Publication Year :
- 2002
-
Abstract
- 2-amino-2-[2-(4-octylphenyl)ethyl] propane-1,3-diol hydrochloride (FTY720), a synthetic product derived from a metabolite of Isaria sinclairii, has been demonstrated to have a potent immunosuppressive activity that induces apoptotic cell death in T cells and several other cell lines. In this study, using the human T-lymphoma cell line, Jurkat cells, we investigated the apoptotic signal transduction mediated by FTY720, in particular comparing its role on the cleavage of caspases, with that mediated by etoposide or anti-Fas antibody. All of these agents cleaved caspases, inducing their active form in the affected cells. Pretreatment with a broad caspase inhibitor [benzyloxycarbonyl-Val-Ala-Asp-(Ome) fluoromethyl ketone] markedly decreased the incidence of apoptotic cells induced by FTY720, etoposide, and anti-Fas antibody, through the abrogation of cleavage of Bid, poly(ADP-ribose) polymerase, and caspases 3, 8, and 9. The overexpression of Bcl-2 gene prevented FTY720- and etoposide-mediated apoptosis, but not Fas-mediated apoptosis. In addition, mitochondria were demonstrated to play a critical role in FTY720-triggered cell death, suggesting that this drug has a potent anticancer activity.
- Subjects :
- Blotting, Western
Caspases metabolism
DNA Fragmentation drug effects
Enzyme Activation drug effects
Enzyme Activators pharmacology
Fingolimod Hydrochloride
Gene Expression Regulation, Neoplastic drug effects
Genes, bcl-2 drug effects
Humans
Indicators and Reagents
Jurkat Cells
Sphingosine analogs & derivatives
Antibodies pharmacology
Antineoplastic Agents, Phytogenic pharmacology
Apoptosis drug effects
Etoposide pharmacology
Immunosuppressive Agents pharmacology
Propylene Glycols pharmacology
fas Receptor immunology
Subjects
Details
- Language :
- English
- ISSN :
- 0022-3565
- Volume :
- 300
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- The Journal of pharmacology and experimental therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 11861801
- Full Text :
- https://doi.org/10.1124/jpet.300.3.939